Atorvastatin Enhance Efficacy of Mesenchymal Stem Cells Treatment for Swine Myocardial Infarction via Activation of Nitric Oxide Synthase
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Atorvastatin Enhance Efficacy of Mesenchymal Stem Cells Treatment for Swine Myocardial Infarction via Activation of Nitric Oxide Synthase
Authors
Keywords
Mesenchymal stem cells, Inflammation, Cardiac transplantation, Apoptosis, Stem cell transplantation, Statins, Nitric oxide, Swine
Journal
PLoS One
Volume 8, Issue 5, Pages e65702
Publisher
Public Library of Science (PLoS)
Online
2013-06-01
DOI
10.1371/journal.pone.0065702
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Autoimmunity against cardiac troponin I in ischaemia reperfusion injury
- (2011) H. Christian Volz et al. EUROPEAN JOURNAL OF HEART FAILURE
- Preventive effects of pravastatin on thrombin-triggered vascular responses via Akt/eNOS and RhoA/Rac1 pathways in vivo
- (2010) H. Ohkawara et al. CARDIOVASCULAR RESEARCH
- Atorvastatin prevents mesenchymal stem cells from hypoxia and serum-free injury through activating amp-activated protein kinase
- (2010) Qiuting Dong et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
- (2010) Carol Kilkenny et al. PLOS BIOLOGY
- Combined Therapy With Simvastatin and Bone Marrow–Derived Mesenchymal Stem Cells Increases Benefits in Infarcted Swine Hearts
- (2009) Yue-Jin Yang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- AMP-Activated Protein Kinase Functionally Phosphorylates Endothelial Nitric Oxide Synthase Ser633
- (2009) Zhen Chen et al. CIRCULATION RESEARCH
- Mesenchymal Stem Cells: A Good Candidate for Restenosis Therapy?
- (2009) Amalia Forte et al. Current Vascular Pharmacology
- New Paradigms of Myocardial Regeneration Post-Infarction
- (2009) James S. Forrester et al. JACC-Cardiovascular Interventions
- Tracking the migration of cardially delivered therapeutic stem cellsin vivo: state of the art
- (2009) N Nyolczas et al. Regenerative Medicine
- The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis
- (2008) A. Blum et al. ATHEROSCLEROSIS
- VEGF improves survival of mesenchymal stem cells in infarcted hearts
- (2008) Jennifer Pons et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide
- (2008) A. T. Gonon et al. CARDIOVASCULAR RESEARCH
- Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts
- (2008) Y.-J. Yang et al. EUROPEAN HEART JOURNAL
- Mesenchymal Stem Cells: Isolation, Characterisation and In Vivo Fluorescent Dye Tracking
- (2008) Christopher Weir et al. Heart Lung and Circulation
- Systems approaches to preventing transplanted cell death in cardiac repair
- (2008) Thomas E. Robey et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Why are MSCs therapeutic? New data: new insight
- (2008) AI Caplan JOURNAL OF PATHOLOGY
- Optimal time for mesenchymal stem cell transplantation in rats with myocardial infarction
- (2008) Chen-yang Jiang et al. Journal of Zhejiang University-SCIENCE B
- Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure
- (2008) Lili Li et al. MOLECULAR BIOLOGY REPORTS
- Concise Review: Mesenchymal Stromal Cells: Potential for Cardiovascular Repair
- (2008) Peter J. Psaltis et al. STEM CELLS
- Dose-Dependent Effects of Intravenous Allogeneic Mesenchymal Stem Cells in the Infarcted Porcine Heart
- (2008) David Wolf et al. STEM CELLS AND DEVELOPMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More